Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors

Advances in Therapy

Volumn 28, Issue 10, 2011, Pages 907-926

  Amin, Alpesh N ^a   Jhaveri, Mehul ^b   Lin, Jay ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANOFI   (France)

^c Novosys Health   (United States)

Author keywords

ATHENA; atrial fibrillation; atrial flutter; burden; comorbidity; cost; hospitalization

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

AGE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG COST; EMBOLISM; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LIKELIHOOD FUNCTIONS; LINEAR MODELS; MALE; MEDICARE; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 82355169018     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-011-0065-6     Document Type: Article

References (38)

1. G.V. Naccarelli H. Varker J. Lin K.L. Schulman 2009 Increasing prevalence of atrial fibrillation and flutter in the United States Am J Cardiol 104 1534 1539 19932788 10.1016/j.amjcard.2009.07.022
2. A.S. Go E.M. Hylek K.A. Phillips Y. Chang L.E. Henault J.V. Selby, et al. 2001 Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2370 2375 11343485 10.1001/jama.285.18.2370 1:STN:280:DC%2BD3M3ntleitQ%3D%3D (Pubitemid 32424106)
3. Y. Miyasaka M.E. Barnes B.J. Gersh S.S. Cha K.R. Bailey W.P. Abhayaratna, et al. 2006 Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119 125 16818816 10.1161/CIRCULATIONAHA.105.595140 (Pubitemid 44420743)
4. W.B. Kannel P.A. Wolf E.J. Benjamin D. Levy 1998 Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 2N 9N 9809895 10.1016/S0002-9149(98)00583-9 1:STN:280:DyaK1M%2FisFOltQ%3D%3D (Pubitemid 28507114)
5. E.J. Benjamin P.A. Wolf R.B. D'Agostino H. Silbershatz W.B. Kannel D. Levy 1998 Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 946 952 9737513 1:STN:280:DyaK1cvgslGgsw%3D%3D (Pubitemid 28446646)
6. S. Stewart C.L. Hart D.J. Hole J.J. McMurray 2002 A population-based study of the long-term risks associated with atrial fibrillation: 20-year followup of the Renfrew/Paisley study Am J Med 113 359 364 12401529 10.1016/S0002-9343(02)01236-6 (Pubitemid 35223606)
7. W.A. Wattigney G.A. Mensah J.B. Croft 2003 Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention Circulation 108 711 716 12885749 10.1161/01.CIR.0000083722.42033.0A (Pubitemid 36999256)
8. F. Khairallah R. Ezzedine L.I. Ganz B. London S. Saba 2004 Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001 Am J Cardiol 94 500 504 15325940 10.1016/j.amjcard. 2004.04.068 (Pubitemid 39120005)
9. Y. Miyasaka M.E. Barnes B.J. Gersh S.S. Cha K.R. Bailey J.B. Seward, et al. 2008 Changing trends of hospital utilization in patients after their first episode of atrial fibrillation Am J Cardiol 102 568 572 18721513 10.1016/j.amjcard.2008.04.025
10. M.H. Kim J. Lin M. Hussein C. Kreilick D. Battleman 2009 Cost of atrial fibrillation in United States managed care organizations Adv Ther 26 847 857 19768638 10.1007/s12325-009-0066-x
11. M.H. Kim S.S. Johnston B.C. Chu M.R. Dalal K.L. Schulman 2011 Estimation of total incremental health care costs in patients with atrial fibrillation in the United States Circ Cardiovasc Qual Outcomes 4 313 320 21540439 10.1161/CIRCOUTCOMES.110.958165
12. S.H. Hohnloser S.J. Connolly H.J. Crijns R.L. Page W. Seiz C. Torp-Petersen 2008 Rationale and design of ATHENA: A placebo-controlled, doubleblind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter J Cardiovasc Electrophysiol 19 69 73 18031520 10.1111/j.1540-8167.2008.01205.x
13. S.H. Hohnloser H.J. Crijns M. van Eickels C. Gaudin R.L. Page C. Torp-Pedersen, et al. 2009 Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 668 678 19213680 10.1056/NEJMoa0803778 1:CAS:528:DC%2BD1MXhvVyisbg%3D
14. E.Q. Wu H.G. Birnbaum M. Mareva E. Tuttle A.R. Castor W. Jackman, et al. 2005 Economic burden and co-morbidities of atrial fibrillation in a privately insured population Curr Med Res Opin 21 1693 1699 16238910 10.1185/ 030079905X65475 (Pubitemid 41505035)
15. W.C. Lee G.A. Lamas S. Balu J. Spalding Q. Wang C.L. Pashos 2008 Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective J Med Econ 11 281 298 19450086
16. Thomson Reuters. MarketScan Studies, Abbreviated Bibliography. Thomson Reuters. Available at: http://img.en25.com/Web/ThomsonReuters/ 2009ThomsonReutersMarketScanBibliography-0.pdf. Last accessed August 2, 2011.
17. G.V. Naccarelli S.S. Johnston J. Lin P.P. Patel K.L. Schulman 2010 Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States Clin Cardiol 33 270 279 20513065 10.1002/clc.20759
18. M.E. Charlson P. Pompei K.L. Ales C.R. MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383 3558716 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D (Pubitemid 17055592)
19. B.F. Gage A.D. Waterman W. Shannon M. Boechler M.W. Rich M.J. Radford 2001 Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2864 2870 11401607 10.1001/jama.285.22.2864 1:STN:280:DC%2BD3MzntFKgsQ%3D%3D (Pubitemid 32537350)
20. M. Hughes G.Y. Lip 2008 Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data Thromb Haemost 99 295 304 18278178 1:CAS:528:DC%2BD1cXisFKmtr0%3D (Pubitemid 351230959)
21. M.H. Kim D. Klingman J. Lin D.S. Battleman 2009 Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation Pharmacotherapy 29 1417 1426 19947801 10.1592/phco.29.12.1417
22. S. Stewart N.F. Murphy A. Walker A. McGuire J.J. McMurray 2004 Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 286 292 14966048 10.1136/hrt.2002.008748 1:STN:280:DC%2BD2c%2FnsleisA%3D%3D (Pubitemid 38250721)
23. K.S. Coyne C. Paramore S. Grandy M. Mercader M. Reynolds P. Zimetbaum 2006 Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States Value Health 9 348 356 16961553 10.1111/j.1524-4733.2006. 00124.x (Pubitemid 44337788)
24. M.H. Kim J. Lin M. Hussein D. Battleman 2009 Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation Curr Med Res Opin 25 1215 1220 19327101 10.1185/03007990902869235 1:STN:280: DC%2BD1Mzgslaktg%3D%3D
25. M.R. Reynolds V. Essebag P. Zimetbaum D.J. Cohen 2007 Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry J Cardiovasc Electrophysiol 18 628 633 17451468 10.1111/j.1540-8167.2007.00819.x (Pubitemid 46800517)
26. Reynolds MR ZP, Diamand F, Jhaveri M, Lin J, Plich A. US cost savings resulting from the dronedaroneassociated reduction in cardiovascular hospitalizations among atrial fibrillation/flutter patients in the ATHENA trial: full study analysis. Available at: http://my.americanheart.org/idc/groups/ ahamah-public/@wcm/@sop/documents/downloadable/ucm-426924.pdf. Last accessed August 29, 2011.
27. Sanofi. Sanofi Provides MultaqPhase IIIb PALLAS Trial Update. Available at: http://en.sanofi.com/ binaries/20110707-PALLAS-en-tcm28-33021.pdf. Last accessed August 10, 2011.
28. A. Goldberg M. Menen S. Mickelsen C. MacIndoe M. Binder R. Nawman, et al. 2003 Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources J Interv Card Electrophysiol 8 59 64 12652179 10.1023/A:1022348216072 (Pubitemid 36356174)
29. M.H. Kim J. Lin C. Kreilick S.H. Foltz Boklage 2010 Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States Adv Ther 27 600 612 20700678 10.1007/s12325-010-0060-3
30. A.J. Camm P. Kirchhof G.Y. Lip U. Schotten J. Savelieva S. Ernst, et al. 2010 Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2369 2429 20802247 10.1093/eurheartj/ehq278
31. M.N. Khan P. Jaïs J. Cummings L. Di Biase P. Sanders D.O. Martin, et al. 2008 Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 1778 1785 18946063 10.1056/NEJMoa0708234 1:CAS:528:DC%2BD1cXht12nu73J
32. M. Jessup W.T. Abraham D.E. Casey A.M. Feldman G.S. Francis T.O. Ganiats, et al. 2009 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 1977 2016 19324967 10.1161/ CIRCULATIONAHA.109.192064
33. L.S. Wann A.B. Curtis C.T. January K.A. Ellenbogen J.E. Lowe N.A. Estes 3rd, et al. 2011 2011 ACCF/ AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 104 123 21173346 10.1161/CIR. 0b013e31820f14c0
34. P.A. Wolf R.D. Abbott W.B. Kannel 1991 Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 983 988 1866765 10.1161/01.STR.22.8.983 1:STN:280:DyaK3Mzislektg%3D%3D
35. V. Fuster L.E. Rydén D.S. Cannom D.S. Crijns A.B. Curtis K.A. Ellenbogen, et al. 2006 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 e257 354 16908781 10.1161/CIRCULATIONAHA.106.177292 (Pubitemid 44252297)
36. P.J. Zimetbaum A. Thosani H.-T. Yu Y. Xiong J. Lin P. Kothawala, et al. 2010 Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med 123 446 453 20399322 10.1016/j.amjmed.2009.11.015 1:CAS:528:DC%2BC3cXkvFelu78%3D
37. Report to Congress: Promoting Greater Efficiency in Medicare. Washington D.C.: Medicare Payment Advisory Commission; June 2007.
38. L. Friberg M. Rosenqvist 2011 Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation Europace 13 626 633 21296777 10.1093/europace/eur001